IGF-1 Can Either Protect Against or Increase LPS-Induced Damage in the Developing Rat Brain
Open Access
- 1 June 2010
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 67 (6) , 579-584
Abstract
Periventricular leukomalacia (PVL) is a major form of brain damage in premature infants. This study was to test whether IGF-1 can prevent PVL-like brain damage induced by lipopolysaccharide (LPS) in the neonatal rat. Intraventricular delivery of LPS resulted in an acute brain inflammatory response, i.e., rapid recruitment of polymorphonuclear leukocytes (PMNs), activation of microglia and astrocytes, and induction of IL-1β (IL1β) expression. Brain inflammation was associated with the loss of O4+ preoligodendrocytes (preOLs), a decrease of myelin basic protein (MBP) in the white matter and an increase of pyknotic cells in the cortex. IGF-1 at a low dose significantly prevented LPS-induced deleterious effects without alteration of IL-1β expression and microglia/astrocytes activation. On the other hand, the low dose of IGF-1 enhanced LPS-induced PMNs recruitment and blood-brain barrier (BBB) permeability, and caused intracerebral hemorrhage. At higher doses, co-application of IGF-1 with LPS resulted in a high mortality rate. Brains from the surviving rats showed massive PMN infiltration and intracerebral hemorrhage. However, these adverse effects were not found in rats treated with IGF-1 alone. This study provides the alarming evidence that in an acute inflammatory condition, IGF-1 may have severe, harmful effects on the developing brain.Keywords
This publication has 25 references indexed in Scilit:
- Pathogenesis of cerebral white matter injury of prematurityArchives of Disease in Childhood - Fetal and Neonatal Edition, 2008
- Sex and the pathogenesis of cerebral palsyDevelopmental Medicine & Child Neurology, 2006
- IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia–ischemia in the neonatal ratBrain Research, 2005
- Selective vulnerability in the developing central nervous systemPediatric Neurology, 2004
- Insulin-like growth factor-1 downregulates nuclear factor κB activation and upregulates interleukin-8 gene expression induced by tumor necrosis factor αBiochemical and Biophysical Research Communications, 2003
- Insulin-Like Growth Factor (IGF)-1 Suppresses Oligodendrocyte Caspase-3 Activation and Increases Glial Proliferation after Ischemia in Near-Term Fetal SheepJournal of Cerebral Blood Flow & Metabolism, 2003
- Insulin-Like Growth Factor-1 Enhances Inflammatory Responses in Endothelial CellsCirculation Research, 2002
- IGF-I Receptor-induced Cell-Cell Adhesion of MCF-7 Breast Cancer Cells Requires the Expression of Junction Protein ZO-1Journal of Biological Chemistry, 2001
- Hypoglycemic Effects of Insulin-Like Growth Factor-1 in Experimental Uremia: Can Concomitant Growth Hormone Administration Prevent This Effect?Hormone Research in Paediatrics, 1999
- Insulin like growth factor-1 activates nuclear factor-κB and increases transcription of the intercellular adhesion molecule-1 gene in endothelial cellsCardiovascular Surgery, 1999